Elderly patients with dementia-related symptoms of severe agitation and aggression: Consensus statement on treatment options, clinical trials methodology, and policy

Journal of Clinical Psychiatry

Volumn 69, Issue 6, 2008, Pages 889-898

  Salzman, Carl ^a   Jeste, Dilip V ^b   Meyer, Roger E ^c   Cohen Mansfield, Jiska ^d   Cummings, Jeffrey ^e   Grossberg, George T ^f   Jarvik, Lissy ^e   Kraemer, Helena C ^g   Lebowitz, Barry D ^b   Maslow, Katie ^h   Pollock, Bruce G ⁱ   Raskind, Murray ^d   Schultz, Susan K ^j   Wang, Philip ^a   Zito, Julie M ^k   Zubenko, George S ^l  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Best Practice Project Management Inc   (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f SAINT LOUIS UNIVERSITY   (United States)

^g STANFORD UNIVERSITY   (United States)

^h ALZHEIMER'S ASSOCIATION   (United States)

ⁱ UNIVERSITY OF TORONTO   (Canada)

^j UNIVERSITY OF IOWA   (United States)

^k UNIVERSITY OF MARYLAND   (United States)

^l UNIVERSITY OF PITTSBURGH   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ARIPIPRAZOLE; ATYPICAL ANTIPSYCHOTIC AGENT; HALOPERIDOL; OLANZAPINE; RISPERIDONE; TRAZODONE;

AGGRESSION; AGITATION; ALGORITHM; BEHAVIOR; BEHAVIOR DISORDER; BRADYKINESIA; CLINICAL TRIAL; CONFERENCE PAPER; DEMENTIA; DRUG APPROVAL; DRUG EFFICACY; DRUG FATALITY; DRUG MARKETING; DRUG MONITORING; DRUG SAFETY; FOOD AND DRUG ADMINISTRATION; GERIATRIC PATIENT; HEALTH CARE POLICY; HUMAN; MEDICAL INFORMATION; MENTAL HEALTH; MORTALITY; NURSING HOME; PARKINSON DISEASE; PATIENT MONITORING; PRIORITY JOURNAL; STROKE; TREATMENT INDICATION; UNSPECIFIED SIDE EFFECT;

EID: 46749128245     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v69n0602     Document Type: Conference Paper

References (42)

1. Levenson S. Evidence-based practice in LTC: the use of antipsychotics in nursing home residents. Caring for the Ages 2003;4:34-35
2. Bolder CR, Jeste DV. Incidence of tardive dyskinesia with typical versus atypical antipsychotics in very high-risk patients. Biol Psychiatry 2003; 53:1142-1145
3. Wang PS, Schneeweiss S, Avorn J, et al. Risk of death in elderly users of conventional vs atypical antipsychotic medications. N Engl J Med 2005 Dec;353(22):2335-2341
4. Schneider LS, Dagemian KS, Insel P. Risk of deatli with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials. JAMA 2005;294:1934-1943
5. Ballard C, Waite J. The effectiveness of atypical antipsychotics for the treatment of aggression and psychosis in Alzheimer's disease. Cochrane Database Syst Rev 2006;1:CD003476
6. Schneider LS, Tariot PN, Dagemian KS, et al. CATIE-AD Study Group. Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease. N Engl J Med 2006 Oct;355(15):1525-1538
7. Katz IR, Jeste DV, Mintzer JE, et al. Comparison of risperidone and placebo for psychosis and behavioral disturbances associated with dementia: a randomized, double-blind trial. Risperidone Study Group. J Clin Psychiatry 1999 Feb;60(2):107-115
8. Brodaty H, Ames D, Snowdon J, et al. A randomized placebo-controlled trial of risperidone for the treatment of aggression, agitation, and psychosis of dementia. J Clin Psychiatry 2003 Feb;64(2):134-143
9. Street JS, Clark WS, Gannon KS, et al. Olanzapine treatment of psychotic and behavioral symptoms in patients with Alzheimer disease in nursing care facilities: a double-blind, randomized, placebo-controlled trial. The HGEU Study Group. Arch Gen Psychiatry 2000 Oct;57(10): 968-976
10. Tariot PN, Schneider L, Katz IR, et al. Quetiapine treatment of psychosis associated with dementia: a double-blind, randomized, placebo-controlled clinical trial. Am J Geriatr Psychiatry 2006;14:767-776
11. Sultzer DL, Gray KF, Gunay I, et al. A double-blind comparison of trazodone and haloperidol for treatment of agitation in patients with dementia. Am J Geriatr Psychiatry 1997;5:60-69
12. Lebert F, Stekke W, Hasenbroekx C, et al. Frontotemporal dementia: a randomised, controlled trial with trazodone. Dement Geriatr Cogn Disord 2004;17:355-359
13. Teri L, Logsdon RG, Peskind E, et al. Treatment of agitation in AD: a randomized, placebo-controlled clinical trial. Neurology 2000;55: 1271-1278
14. Tariot PN, Erb R, Leibovici A, et al. Carbamazepme treatment of agitation in nursing home patients with dementia: a preliminary study. J Am Geriatr Soc 1994;42:1160-1166
15. Pollock BG, Mulsant BH, Rosen J, et al. Comparison of citalopram, perphenazine and placebo for the acute treatment of psychosis and behavioral disturbances in hospitalized, demented patients. Am J Psychiatry 2002;159:460-465
16. Olafsson K, Jorgensen S, Jensen HV, et al. Fluvoxamine in the treatment of demented elderly patients: a double-blind, placebo-controlled study. Acta Psychiatr Scand 1992;85:453-456
17. Calkin PA, Kunik ME, Orengo CA, et al. Tolerability of clonazepam in demented and non-demented geropsychiatric patients. Int J Geriatr Psychiatry 1997;12:745-749
18. Meehan KM, Wang H, David SR, et al. Comparison of rapidly acting intramuscular olanzapine, lorazepam and placebo: a double-blind, randomized study in acutely agitated patients with dementia. Neuropsychoparmacology 2002 Apr;26(4):494-504
19. Gauthier S, Feldman H, Hecker J, et al. Functional, cognitive, and behavioral effects of donepezil in patients with moderate Alzheimer's disease. CurrMed Res Opin 2002;18(6):347-354
20. Tariot PN, Cummings JL, Katz IR et al. A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting. J Am Geriatr Soc 2001;49:1590-1599
21. Jeste DV, Sable JA, Salzman. C. Treatment of late-life disordered behavior, agitation and psychosis. In: Salzman C, ed. Clinical Geriatric Psychopharmacology, 4th ed. Philadelphia, Pa: Lippincott, Williams and Wilkins; 2005:130-195
22. Jeste DV, Finkel SI. Psychosis of Alzheimer's disease and related dementias: diagnostic criteria for a distinct syndrome. Am J Geriatr Psychiatry 2000;8:29-34
23. Laughren T. A regulatory perspective on psychiatric syndromes in Alzheimer disease. Am J Geriatr Psychiatry 2001;9:340-345
24. Sultzer DL, Brown CV, Mandelkem MA, et al. Delusional thoughts and regional frontal/temporal cortex metabolism in Alzheimer's disease. Am J Psychiatry 2003;160:341-349
25. Zubenko GS. Neurobiology of Alzheimer's disease. In: Salzman C, ed. Clinical Geriatric Psychopharmacology, 4th ed. Philadelphia, Pa: Lippincott, Williams and Wilkins; 2005:544-593
26. von Moltke LL, Abernethy DR, Greenblatt DJ. Kinetics and dynamics of psychotropic drugs in the elderly. In: Salzman C, ed. Clinical Geriatric Psychopharmacology, 4th ed. Philadelphia, Pa: Lippincott, Williams and Wilkins; 2005:87-114
27. Pollock BG. Geriatric psychiatry: psychopharmacology: general principles. In: Sadock BJ, Sadock VA, eds. Kaplan & Sadock's Comprehensive Textbook of Psychiatry, 5 th ed. Baltimore, Md: Williams & Wilkins; 2005:3716-3720
28. FDA Public Health Advisory. Deaths With Antipsychotics in Elderly Patients With Beliavioral Disturbances. April 11,2005. Available at: http://www.fda.gov/cder/drug/advisory/antipsychotics.htm. Accessed Feb 22, 2008
29. Jin H, Meyer JM, Jeste DV. Atypical antipsychotios and glucose dysregulation: a systematic review. Schizophr Res 2004;71:195-212
30. Cohen-Mansfield J, Marx MS, Rosenthal AS. A description of agitation in a nursing home. J Gerontol 1989;44:M77-M84
31. Cohen-Mansfield J. Nonpharmacological management of behavioral problems in persons with dementia: the TREA model. Alzheimer's Care Quarterly 2000;1:22-34
32. Cohen-Mansfield J. Nonpharmacologic interventions for inappropriate behaviors in dementia: a review, summary, and critique. Am J Geriatr Psychiatry 2001;9:361-381
33. Sloane PD, Hoeffer B, Mitchell CM, et al. Effect of person-centered showering and the towel bath on bathing-associated aggression, agitation, and discomfort in nursing home residents with dementia: a randomized controlled trial. J Am Geriatr Soc 2004;52:1795-1804
34. Fossey J, Ballard C, Juszczak E, et al. Effect of enhanced psychosocial care on antipsychotic use in nursing home residents with severe dementia: cluster randomized trial. BMJ 2006;332:756-761
35. Cohen-Mansfield J, Libin A, Marx MS. Nonpharmacological treatment of agitation: a controlled trial of systematic individualized intervention. J Gerontol A Biol Sci Med Sci 2007;62:908-916
36. Hepburn KW, Lewis M, Sherman CW, et al. The Savvy Caregiver Program: developing and testing a transportable dementia family caregiver training program. Gerontologist 2003;43:908-915
37. Kovach CR, Taneli Y, Dohearty P, et al. Effect of the BACE intervention on agitation in people with dementia. Gerontologist 2004;44:797-806
38. Teri L, McCurry SM, Logsdon R, et al. Training community consultants to help family members improve dementia care: a randomized controlled trial. Gerontologist 2005;45:802-811
39. Ostwald SK, Hepburn KW, Caron W, et al. Reducing caregiver burden: a randomized psychoeducational intervention for caregivers of persons with dementia. Gerontologist 1999;39:299-309
40. Belle SH, Burgio L, Bums R. Enhancing the quality of life of dementia caregivers from different ethnic and racial groups: a randomized controlled trial. Ann Intern Med 2006;145:727-738
41. Teri. L, Gibbons LE, McCurry SM, et al. Exercise plus behavioral management in patients with Alzheimer's disease: a randomized trial. JAMA 2003;290:2015-2022
42. Teri L, Logsdon RG, Uomoto J, et al. Beliavioral treatment of depression in dementia patients: a controlled clinical trial. J Gerontol B Psychol Sci. Soc Sci .1997 Jul;52(4):P159-P166.